Standard
The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR alpha-mAb treatment in rheumatoid arthritis patients. / Mortensen, J.; Guo, X.; De Los Reyes, M.; Dziegiel, M.; Karsdal, M.; Bay-Jensen, A.; White, W.
In:
Clinical and Experimental Rheumatology, Vol. 37, No. 1, 2019.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Mortensen, J, Guo, X, De Los Reyes, M
, Dziegiel, M, Karsdal, M, Bay-Jensen, A & White, W 2019, '
The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR alpha-mAb treatment in rheumatoid arthritis patients',
Clinical and Experimental Rheumatology, vol. 37, no. 1. <
https://www.clinexprheumatol.org/abstract.asp?a=12587>
APA
Mortensen, J., Guo, X., De Los Reyes, M.
, Dziegiel, M., Karsdal, M., Bay-Jensen, A., & White, W. (2019).
The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR alpha-mAb treatment in rheumatoid arthritis patients.
Clinical and Experimental Rheumatology,
37(1).
https://www.clinexprheumatol.org/abstract.asp?a=12587Vancouver
Mortensen J, Guo X, De Los Reyes M, Dziegiel M, Karsdal M, Bay-Jensen A et al. The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR alpha-mAb treatment in rheumatoid arthritis patients. Clinical and Experimental Rheumatology. 2019;37(1).
Author
Mortensen, J. ; Guo, X. ; De Los Reyes, M. ; Dziegiel, M. ; Karsdal, M. ; Bay-Jensen, A. ; White, W. / The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR alpha-mAb treatment in rheumatoid arthritis patients. In: Clinical and Experimental Rheumatology. 2019 ; Vol. 37, No. 1.
Bibtex
@article{bc37c5f551fd42aca581fee4cf4d5521,
title = "The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR alpha-mAb treatment in rheumatoid arthritis patients",
keywords = "macrophages, biomarker, citrullination, vimentin, rheumatoid arthritis, autoimmunity, anti-GM-CSF, matrix metalloproteinase",
author = "J. Mortensen and X. Guo and {De Los Reyes}, M. and M. Dziegiel and M. Karsdal and A. Bay-Jensen and W. White",
year = "2019",
language = "English",
volume = "37",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Pacini Editore SpA",
number = "1",
}
RIS
TY - JOUR
T1 - The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR alpha-mAb treatment in rheumatoid arthritis patients
AU - Mortensen, J.
AU - Guo, X.
AU - De Los Reyes, M.
AU - Dziegiel, M.
AU - Karsdal, M.
AU - Bay-Jensen, A.
AU - White, W.
PY - 2019
Y1 - 2019
KW - macrophages
KW - biomarker
KW - citrullination
KW - vimentin
KW - rheumatoid arthritis
KW - autoimmunity
KW - anti-GM-CSF
KW - matrix metalloproteinase
M3 - Journal article
C2 - 30418117
VL - 37
JO - Clinical and Experimental Rheumatology
JF - Clinical and Experimental Rheumatology
SN - 0392-856X
IS - 1
ER -
